Skip to main content

Imunon, Inc.

IMNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000749647

In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Imunon, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of IMNN: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders40142+3
Shares9.24M150.0K7.68M−1.41M (−15.5%)
Value$8.54M$139.0K$4.14M−$4.25M (−50.7%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Imunon, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to IMNN in Q4 2021
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC108,638$59.0K0.00%
Virtu Financial LLC101,652$55.0K0.01%
FNY Investment Advisers, LLC65,000$35.0K0.02%
Millennium Management LLC41,772$23.0K0.00%
Two Sigma Securities, LLC30,148$16.0K0.00%
Assenagon Asset Management S.A.20,491$11.0K0.00%
CWM, LLC1$00.00%
Tyler-Stone Wealth Management2$00.00%

Sold out (5)

Institutions that held Imunon, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of IMNN in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Barclays PLC25,875$24.0K
Qube Research & Technologies Ltd25,875$24.0K
FMR LLC1,578$1.00K
Montag A & Associates Inc105$0
Tower Research Capital LLC (TRC)244$0

Not filed for Q4 2021 yet (1)

Institutions that held Imunon, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMNN in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Eudaimonia Partners, LLC150,000$139.0K